Yara Blok

78 Chapter 5 REFERENCES 1. Bertozzi N, Pesce M, Santi P, Raposio E. Tissue expansion for breast reconstruction: Methods and techniques. Ann Med Surg (Lond) 2017; 21:34-44. 2. Cemal Y, Albornoz CR, Disa JJ, et al. A paradigm shift in U.S. breast reconstruction: Part 2. The influence of changing mastectomy patterns on reconstructive rate and method. Plast Reconstr Surg 2013; 131(3):320e-326e. 3. Albornoz CR, Bach PB, Mehrara BJ, et al. A paradigm shift in U.S. Breast reconstruction: increasing implant rates. Plast Reconstr Surg 2013; 131(1):15-23. 4. Sinha I, Pusic AL, Wilkins EG, et al. Late Surgical-Site Infection in Immediate ImplantBased Breast Reconstruction. Plast Reconstr Surg 2017; 139(1):20-28. 5. Poppler LH, Mundschenk MB, Linkugel A, et al. Tissue Expander Complications Do Not Preclude a Second Successful Implant-Based Breast Reconstruction. Plast Reconstr Surg 2019; 143(1):24-34. 6. Darragh L, Robb A, Hardie CM, et al. Reducing implant loss rates in immediate breast reconstructions. Breast 2017; 31:208-213. 7. Knight HJ, Musgrove JJ, Youssef MMG, et al. Significantly reducing implant loss rates in immediate implant-based breast reconstruction: A protocol and completed audit of quality assurance. J Plast Reconstr Aesthet Surg 2020; 73(6):1043-1049. 8. Ozturk CN, Ozturk C, Soucise A, et al. Expander/Implant Removal After Breast Reconstruction: Analysis of Risk Factors and Timeline. Aesthetic Plast Surg 2018; 42(1):6472. 9. Sue GR, Sun BJ, Lee GK. Complications After Two-Stage Expander Implant Breast Reconstruction Requiring Reoperation: A Critical Analysis of Outcomes. Ann Plast Surg 2018; 80(5S Suppl 5):S292-s294. 10. Fischer JP, Wes AM, Tuggle CT, 3rd, et al. Risk analysis of early implant loss after immediate breast reconstruction: a review of 14,585 patients. J Am Coll Surg 2013; 217(6):983-90. 11. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. Jama 2013; 310(20):2191-4. 12. von Elm E, Altman DG, Egger M, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Bmj 2007; 335(7624):806-8. 13. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004; 240(2):205-13. 14. Hirsch EM, Seth AK, Kim JYS, et al. Analysis of risk factors for complications in expander/ implant breast reconstruction by stage of reconstruction. Plast Reconstr Surg 2014; 134(5):692e-699e. 15. Francis SH, Ruberg RL, Stevenson KB, et al. Independent risk factors for infection in tissue expander breast reconstruction. Plast Reconstr Surg 2009; 124(6):1790-1796. 16. McCarthy CM, Mehrara BJ, Riedel E, et al. Predicting complications following expander/ implant breast reconstruction: an outcomes analysis based on preoperative clinical risk. Plast Reconstr Surg 2008; 121(6):1886-1892. 17. Woerdeman LA, Hage JJ, Hofland MM, Rutgers EJ. A prospective assessment of surgical risk factors in 400 cases of skin-sparing mastectomy and immediate breast reconstruction with implants to establish selection criteria. Plast Reconstr Surg 2007; 119(2):455-63. 18. Silverstein P. Smoking and wound healing. Am J Med 1992; 93(1a):22s-24s.

RkJQdWJsaXNoZXIy MTk4NDMw